Interferon-alpha 2a treatment of neuro-Behcet disease

J Neuroophthalmol. 2001 Jun;21(2):109-11. doi: 10.1097/00041327-200106000-00011.

Abstract

Behcet disease is a multisystemic, chronic, recurrent inflammatory disorder characterized as a triad of hypopyon uveitis, oral aphthae, and genital ulcers. Neurologic involvement in Behcet disease (neuro-Behcet) is common. Neuro-Behcet disease typically manifests late after disease onset, rarely coincides with ocular involvement, and often heralds a poor prognosis for final vision and survival. We present a case of neuro-Behcet disease with neurologic onset concomitant with systemic and ocular involvement that was responsive to treatment with interferon-alpha 2a.

Publication types

  • Case Reports

MeSH terms

  • Behcet Syndrome / diagnosis
  • Behcet Syndrome / drug therapy*
  • Brain Diseases / diagnosis
  • Brain Diseases / drug therapy*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use*
  • Magnetic Resonance Imaging
  • Male
  • Papilledema / diagnosis
  • Papilledema / drug therapy
  • Recombinant Proteins

Substances

  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins